Bill > S2313

Introduced Session

This bill limits the sale of tetrahydrocannabinol products in the State. Under the bill, the sale of products containing certain amounts of tetrahydrocannabinol, as prescribed by the Cannabis Regulatory Commission (commission), would be limited to entities licensed by the commission. Tetrahydrocannabinol is defined as: (1) any tetrahydrocannabinol, including delta-8-tetrahydrocannabinol, delta-9- tetrahydrocannabinol, and delta-10- tetrahydrocannabinol, regardless how derived; and (2) any other chemically similar compound, substance, derivative, or isomer of tetrahydrocannabinol, as identified by the commission. It is not a violation of the bill for a person to sell or distribute a product containing tetrahydrocannabinol while that person has a pending application with the commission to be licensed by such authority. However, it is a violation of this bill to sell tetrahydrocannabinol in any amount to a person under the age of 21. Any entity or person that sells a tetrahydrocannabinol product containing an amount in excess to relevant rules or regulations and is not licensed by the commission and does not have a pending license application is subject to any existing fines or penalties established for violators of relevant commission regulations.

Committee Categories

Paul Moriarty (D)*,  Teresa Ruiz (D)*, 

Introduced in the Senate, Referred to Senate Judiciary Committee (on 01/25/2024)

Official Document